A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.
Manufactured by
B&C Biological
China
Shanghai B&C Biological Technology Co., Ltd., established in 2005, is a high-tech enterprise specializing in medical equipment and reagent R&D, manufacturing, sales, and service. ISO13485/ISO9001 certified with multiple patents, the company focuses on cardiovascular disease diagnostics, infectious disease diagnostics, automation instruments, and precision medicine. Since 2016, B&C has been a wholly-owned subsidiary of Skyray Instrument (Stock: 300165).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 2 relevant products
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
27 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 38 closest product alternatives
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Guangzhou Wondfo Biotech Co., Ltd. · China
Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
35 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products